203 related articles for article (PubMed ID: 32407311)
1. Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Nishi M; Kimura T; Igeta M; Furuta M; Suenaga K; Matsumura T; Fujimura H; Jinnai K; Yoshikawa H
PLoS One; 2020; 15(5):e0224912. PubMed ID: 32407311
[TBL] [Abstract][Full Text] [Related]
2. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
3. Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA sequencing.
Yoshizumi K; Nishi M; Igeta M; Nakamori M; Inoue K; Matsumura T; Fujimura H; Jinnai K; Kimura T
Neurosci Res; 2024 Mar; 200():48-56. PubMed ID: 37806497
[TBL] [Abstract][Full Text] [Related]
4. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
5. Macroscopic and microscopic diversity of missplicing in the central nervous system of patients with myotonic dystrophy type 1.
Furuta M; Kimura T; Nakamori M; Matsumura T; Fujimura H; Jinnai K; Takahashi MP; Mochizuki H; Yoshikawa H
Neuroreport; 2018 Feb; 29(3):235-240. PubMed ID: 29381654
[TBL] [Abstract][Full Text] [Related]
6. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
[TBL] [Abstract][Full Text] [Related]
7. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
10. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
12. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
14. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
[TBL] [Abstract][Full Text] [Related]
15. Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1.
Coleman SM; Prescott AR; Sleeman JE
Biochem J; 2014 Mar; 458(2):267-80. PubMed ID: 24354850
[TBL] [Abstract][Full Text] [Related]
16. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.
Llamusi B; Bargiela A; Fernandez-Costa JM; Garcia-Lopez A; Klima R; Feiguin F; Artero R
Dis Model Mech; 2013 Jan; 6(1):184-96. PubMed ID: 23118342
[TBL] [Abstract][Full Text] [Related]
17. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
[TBL] [Abstract][Full Text] [Related]
19. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
20. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
Nutter CA; Kidd BM; Carter HA; Hamel JI; Mackie PM; Kumbkarni N; Davenport ML; Tuyn DM; Gopinath A; Creigh PD; Sznajder ŁJ; Wang ET; Ranum LPW; Khoshbouei H; Day JW; Sampson JB; Prokop S; Swanson MS
Brain; 2023 Oct; 146(10):4217-4232. PubMed ID: 37143315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
